Literature DB >> 22922935

Fresh frozen plasma in the treatment of ACE inhibitor-induced angioedema.

Michael Stewart1, Ray McGlone.   

Abstract

Angioedema secondary to the use of ACE-inhibitors is well recognised, with a high rate of airway intervention required. Several treatments have been described, but little evidence exists for any of them. We describe the successful use of fresh frozen plasma in two cases.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22922935      PMCID： PMC4544408          DOI： 10.1136/bcr-2012-006849

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

1.  Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema.

Authors:  Mohammed Yousuf Karim; Amina Masood
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

Review 2.  ACE inhibitor-induced angioedema.

Authors:  Monali Vasekar; Timothy J Craig
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

Review 3.  Angioedema.

Authors:  Allen P Kaplan; Malcolm W Greaves
Journal:  J Am Acad Dermatol       Date:  2005-09       Impact factor: 11.527

4.  Idiopathic non-histaminergic angio-oedema after routine extubation successfully treated with fresh frozen plasma.

Authors:  D Franzen; T Ursprung; B Wuthrich; A Reber
Journal:  Anaesthesia       Date:  2006-07       Impact factor: 6.955

5.  Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery.

Authors:  C J Jaffe; J P Atkinson; J A Gelfand; M M Frank
Journal:  J Allergy Clin Immunol       Date:  1975-06       Impact factor: 10.793

6.  Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.

Authors:  Murat Bas; Jens Greve; Klaus Stelter; Henning Bier; Thomas Stark; Thomas K Hoffmann; Georg Kojda
Journal:  Ann Emerg Med       Date:  2010-05-05       Impact factor: 5.721

7.  Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.

Authors:  E W Nielsen; S Gramstad
Journal:  Acta Anaesthesiol Scand       Date:  2006-01       Impact factor: 2.105

Review 8.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

9.  Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema.

Authors:  Manoj R Warrier; Cori A Copilevitz; Mark S Dykewicz; Raymond G Slavin
Journal:  Ann Allergy Asthma Immunol       Date:  2004-05       Impact factor: 6.347

10.  Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital.

Authors:  Damanpaul Sondhi; Michael Lippmann; Ganesan Murali
Journal:  Chest       Date:  2004-08       Impact factor: 9.410
View more
  5 in total

1.  Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts.

Authors:  Marco Cicardi; Paolo Bellis; Giuliano Bertazzoni; Mauro Cancian; Maurizio Chiesa; Paolo Cremonesi; Pietro Marino; Nicola Montano; Claudia Morselli; Francesco Ottaviani; Roberto Perricone; Massimo Triggiani; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2013-09-04       Impact factor: 3.397

2.  Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema.

Authors:  Cheng Gang; Christopher J Lindsell; Joseph Moellman; Wesley Sublett; Kim Hart; Sean Collins; Jonathan A Bernstein
Journal:  Allergy Asthma Proc       Date:  2013 May-Jun       Impact factor: 2.587

3.  Recurrent Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Refractory to Fresh Frozen Plasma.

Authors:  Danessa Vázquez-Ramos; Arelis Cordero-Gomez; William Rodríguez-Cintrón
Journal:  Fed Pract       Date:  2019-12

Review 4.  Efficacy of Treatment of Non-hereditary Angioedema.

Authors:  Mignon van den Elzen; M F C L Go; A C Knulst; M A Blankestijn; H van Os-Medendorp; H G Otten
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

5.  Angioedema, ACE inhibitor and COVID-19.

Authors:  Ekjot Grewal; Bayu Sutarjono; Ibbad Mohammed
Journal:  BMJ Case Rep       Date:  2020-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.